Services

Pharmaco Epidemiology, Post Commercialization Studies

The Mapi Group has the goal and capacity to provide our clients in the Pharmaceutical, Biotechnology, Medical Device and Consumer Products industries with a full-service Epidemiology department.

This includes the ability to provide both strategic advice and perform activities related to market forecasting, market development, pharmacoeconomics, evidence-based medicine, disease modeling, genetic epidemiology, personalised medicine, pharmacovigilance(product surveillance) and product risk management.

We have extensive experience in the design and conduct of pharmacoepidemiology studies. These include the use of health care databases, retrospective studies of medical records, population based case-control studies and large, multinational prospective studies for assessment of health outcomes and post-marketing surveillance.

We maintain a core group of epidemiologists, medical doctors, statisticians, clinical research associates and data management professionals to provide the highest level of quality to all aspects of the design and conduct of all our customers' projects. In addition, we maintain close working relationships with local experts and other contract research organisations to ensure that we deliver all our clients' projects with efficiency, accuracy and speed.

We work together with you on your strategy, aid in regulatory negotiations, set up and conduct necessary activities (literature review, models, studies, identify and work with Key Opinion Leaders) and communicate results at several levels (through regulatory documents, scientific publications, visual presentation aids, interactive communication and training facilities).

Visit the site of the Mapi Group Company that specializes in this service.